The emerging role of γδ T cells in cancer immunotherapy

Immuno-Oncology and Technology

Oliver Nussbaumer¹  Michael Koslowski² 

[1] GammaDelta Therapeutics Ltd, London, UK;corresponding author: Michael Koslowski, Chief Medical Officer, GammaDelta Therapeutics Ltd, The Westworks, 195 Wood Lane, London, W12 7FQ, UK. Tel.: [phone].;

关键词: γδ T cells;    Adoptive cell therapy;    Immunotherapy;    Cancer;   

DOI  :  

来源: DOAJ

【 摘 要 】

The recent successes of chimeric antigen receptor T cells in the treatment of hematological malignancies have clearly led to an explosion in the field of adoptive cell therapy for cancer. Current efforts are focused on the translation of this exciting technology to the treatment of solid tumors and the development of allogeneic ‘off-the-shelf’ therapies. γδ T cells are currently gaining considerable attention in this field as their unique biology and established role in cancer immunosurveillance place them in a unique position to potentially overcome these challenges in adoptive cell therapy. Here, we review the relevant aspects of the function of γδ T cells in cancer immunity, and summarize clinical observations and clinical trial results that highlight their emerging role as a platform for the development of safe and effective cancer immunotherapies.

【 授权许可】

Unknown